SCHEMBL4906191

SCHEMBL4906191

CCN(c1ccc(Oc2ccncc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 4/20 0.41
MMP13 P45452 2/20 0.41
MMP1 P03956 1/20 0.41
ESR1 P03372 2/20 0.39
THRB P10828 1/20 0.39
MMP2 P08253 2/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MCL1 Q07820 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TP53 P04637 1/20 0.38
HDAC8 Q9BY41 1/20 0.37
NR3C1 P04150 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903956 0.90 ESR1 (0.48) MMP9MMP13MMP1ESR1MMP2
SCHEMBL4905211 0.90 LMNA (0.46) MMP9MMP13MMP1ESR1ALDH1A1
SCHEMBL4900707 0.90 TP53 (0.44) MMP9MMP13MMP1MMP2ALDH1A1
SCHEMBL4898047 0.89 MAPT (0.47) MMP9ESR1MMP2ALDH1A1TSHR
SCHEMBL4904286 0.89 MAPT (0.45) MMP9ESR1MMP2ALDH1A1TSHR
SCHEMBL4900752 0.89 ALDH1A1 (0.44) MMP9MMP13MMP1ESR1THRB
SCHEMBL4906457 0.89 MCL1 (0.41) MMP9ESR1THRBMMP2ALDH1A1
SCHEMBL4906417 0.88 HDAC8 (0.52) MMP9MMP2MAPTNPSR1HDAC8
SCHEMBL4904184 0.87 HCRTR2 (0.50) MMP9ESR1MMP2ALDH1A1LMNA
SCHEMBL4908351 0.86 LMNA (0.45) ESR1THRBALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MMP9 4666/4885MMP13 3379/4885MMP1 4641/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MMP9 4632/4885MMP13 3079/4885MMP1 4581/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MMP9 4632/4885MMP13 3079/4885MMP1 4581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.